Magsari, Rowena .
HRN: 21-95-52 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/13/2022
MEBENDAZOLE 100MG/5ML, 60ML SUSPENSION
10/13/2022
10/16/2022
PO
5ml
BID
Ascariasis; Trichiuriasis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes